Inhibition of TNF-α expression by adenosine: Role of A3 adenosine receptors

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3435-3442

  Sajjadi, Fereydoun G ^a   Takabayashi, Ken ^a   Foster, Alan C ^a   Domingo, Ron C ^a   Firestein, Gary S ^a,b  

^a Gensia Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 6 N (4 AMINO 3 IODOBENZYL)ADENOSINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLOHEXYLADENOSINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

ADENOSINE; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN KINASES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029915543     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313.
2. Manogue, K. R., S. J. H. Van Deventer, and A. Cerami. 1992. Tumor necrosis factor-α or cachectin. In The Cytokine Handbook. A. Thomson, ed. Academic Press, Inc., San Diego, p. 241.
3. Firestein, G. S. 1994. Rheumatoid synovitis and pannus. In Rheumatology. J. Klippel and P. Dieppe, eds. Mosby, St. Louis, pp. 3.12.1-3.12.30.
4. Novgrodski, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319.
5. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
6. Doherty, G. M., J. C. Jensen, H. R. Alexander, C. M. Buresh, and J. A. Norton. 1991. Pentoxyfilline suppression of tumor necrosis factor gene expression. Surgery 110:192.
7. Moreira, A. L., E. P. Sampaio, A. Zumuidzinas, P. Frindt, K. A. Smith, and G. Kaplan. 1993. Thalidomide exerts its inhibitory action on tumor necrosis factor-α by enhancing mRNA degradation. J. Exp. Med. 177:1675.
8. Mohler, K. M., P. R. Sleath, I. N. Fitzner, D. P. Cerretti, M. Alderson, S. S. Kerwar, D. S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S. R. Kronheim, M. Petersen, M. Gerhart, C. J. Kozlosky, C. J. March, and R. A. Black. 1994. Protection against a lethal dose of tumour necrosis factor processing. Nature 370:218.
9. McGeehan, G. M., J. D. Becherer, R. C. Bast, C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, A. B. McElroy, J. Nichols, K. M. Pryzwansky, F. Shoenen, L. Sekut, A. Truesdale, M. Verghese, J. Warner, and J. P. Ways. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370:558.
10. Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A. and Ware, C. F. 1995. A metalloprotease inhibitor blocks shedding of the 80-kd TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205.
11. Parmely, M. J., W. W. Zhou, C. K. Edwards, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389.
12. + antigen expression. J. Leukocyte Biol. 56:133.
13. Bradshaw, M., M. S. Rutherford, B. J. Hoeper, C. D. McWhinney, D. R. Borcherding, L. B. Shook, and C. K. Edwards. 1995. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-α gene expression and protein production using novel enantiomeric carboxylic nucleoside analogues. J. Pharmacol. Exp. Ther. 273:1506.
14. Firestein, G. S., D. Boyle, D. A. Bullogh, H. E. Gruber, F. G. Sajjadi, A. Montag, B. Sambol, and K. M. Mullane. 1994. Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol. 152:5853.
15. Bouma, M. G., R. K. Stad, F. A. J. M. van den Wildenberg, and W. A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159.
16. Palmer, T. M., and G. L. Stiles. 1994. The new biology of adenosine receptors. Adv. Enzymol. Relat. Areas Mol. Biol. 69:83.
17. Sajjadi, F. G., and G. S. Firestein. 1993. cDNA cloning and sequence analysis of the human A3 adenosine receptor. Biochem. Biophys. Acta 1179:105.
18. Collis, M. G., and S. M. O. Hourani. Adenosine receptor subtypes. 1993. Tips 14:360.
19. Greenberg, M. E., and T. P. Bender. 1995. Perparation and analysis of RNA. In Current Protocols in Molecular Biology. F. M. Ausubel and K. Struhl, eds. Wiley Interscience, New York, pp. 4.0.1-4.9.12.
20. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17:565.
21. Schreiber, E., P. Mattias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucleic Acids Res. 17:6419.
22. Salvatore, C. A., M. A. Jacobson, H. E. Taylore, J. Linden, and R. G. Johnson. 1993. Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 90:10365.
23. Firestein, G. S., D. L. Boyle, C. Yu, M. M. Paine, T. D. Whisenand, N. J. Zvaifler, and W. P. Arend. 1994. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum. 37:644.
24. Janson, R. W., K. R. Hance, and W. P. Arend. 1991. Production of IL-1 receptor antagonist by human in in vitro-derived macrophages: effects of lipopolysaccharide and granulocyte-macrophage colony-stimulationg factor. J. Immunol. 147: 4218.
25. Linden, J. 1994. Cloned adenosine A3 receptors: pharmacological properties, species differences, and receptor functions. Trends Pharmacol. Sci. 15:298.
26. Gallo-Rodriguez, C., X.-D. Ji, N. Melman, B. D. Siegman, L. H. Sanders, J. Orlina, B. Fischer, Q. Pu, M. E. Olah, P. J. M. van Galen, G. L. Stiles, and K. A. Jacobson. 1994. J. Med. Chem. 37:635.
27. Tannenbaum, C. S., and T. A. Hamilton. 1989. LPS-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular CAMP. J. Immunol. 142:1274.
28. Newell, C. L., A. B. Deisseroth, and G. Lopez-Berestein. 1994. Interaction of nuclear proteins with an AP1/CRE-like promoter sequence in the human TNF-α gene. J. Leukocyte Biol. 56:27.
29. Feoktistov, I., and I. Biaggoni. 1993. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes Mol. Pharmacol. 43:909.
30. Brackett, L. E., and J. W. Daly. 1994. Functional characterization of the A2b adenosine receptor in NIH3T3 fibroblasts. Biochem. Pharmacol. 47:801.
31. Ali, H., J. R. Cunha-Melo, W. F. Saul, and M. A. Beaven. 1990. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. J. Biol. Chem. 265:745.
32. Ramkumar, V., G. L. Stiles, M. Beaven, and H. Ali. 1993. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:16887.
33. Marquardt, B., D. Firth, and S. Stabel. 1994. Signaling from TPA to MAP kinase requires protein kinase C, raf, and MEK: reconstitution of signaling pathway in vitro. Oncogene 9:3213.
34. Liu, M. K., P. Herrera-Velit, R. W. Brownsey, and N. E. Reiner. 1994. CD14-dependent activation of protein kinase C and mitogen-activated kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:2642.
35. Shapira, L., S. Takashiba, C. Champagne, S. Amar, and T. E. Van Dyke. 1994. Involvement of protein kinase C and protein kinase in lipopolysaccharide-induced TNF-α and IL-1β production in human monocytes. J. Immunol. 153:1818.
36. Weinstein, S. L., M. R. Gold, and A. L. DeFranco. 1991. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci. USA 88:4148.
37. Gray, J. G., G. Chandra, W. C. Clay, S. W. Stinnett, S. A. Haneline, J. J. Lorenz, I. R. Patel, G. B. Wisely, P. J. Furdon, J. D. Taylor, and T. A. Kost. 1993. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin-1β gene is necessary for induction in U937 and THP-1 monocytic cell lines. Mol. Cell. Biol. 13:6678.
38. Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways, and J. G. Gray. 1994. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and nonconsensus CRE-like site. J. Immunol. 153: 712.
39. Takashiba, S., L. Shapira, S. Amar, and T. E. Van Dyke. 1993. Cloning and characterization of human TNF-α promoter region. Gene 131:307.
40. Geng, Y., B. Xhang, and M. Lotz. 1993. Protein lyrosinc kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151:6692.
41. English, B. K., J. N. Ihle, A. Myracle, and T. Yi. 1993. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J. Exp. Med. 178:1017.
42. Stefanova, I., M. L. Corcoran, E. M. Horak, L. M. Wahl, J. B. Bolen, and I. D. Horak. 1993. Liposaccharide induces activation of CD14-associated protein tyrosine kinase p53/56 lyn. J. Biol. Chem. 268:20725.
43. Delude, R. L., M. J. Fenton, R. Savedra, P. Perera, S. N. Vogel, R. Thieringer, and D. T. Golenbock. 1994. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:22253.
44. Haas, J. G., P. A. Baeuerle, G. Riethmuller, and H. W. Ziegler-Heitbrock. 1990. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc. Natl. Acad. Sci. USA 87:9563.
45. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
46. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Ruble, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase family of c-jun kinases. Nature 369:156.
47. Brach, M. A., H. Gruss, C. Scott, and F. Herrmann. 1993. The mitogenic response to tumor necrosis factor-α requires c-jun/AP1. Mol. Cell. Biol. 13:4284.
48. Fujihara, M., M. Muroi, Y. Muroi, N. Ito, and T. Suzuki. 1993. Mechanism of lipopolysaccharide-triggered jun B activation in a mouse macrophage-like cell line (J774). J. Biol. Chem. 268:14898.